Kanesa-thasan Niranjan
- SEC CIK
- 0001874021
No open-market purchases or sales filed in the past year.
Current role at each company
- ICVX Icosavax, Inc.Other: See Remarksas of Feb 20, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Kanesa-thasan Niranjan as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 5, 2024 (view filing) | Jan 4, 2023 | 366 daysLate | Kanesa-thasan NiranjanChief Medical Officer | SSale | −106.4K | $15.70 | −$1.67M | −32.2%224.0K after | |
| Dec 22, 2023 (view filing) | Dec 20 | 2 days | Kanesa-thasan NiranjanChief Medical Officer | SSale | −11.9K | $15.46 | −$183.7K | −5.0%224.0K after | |
| Aug 1, 2023 (view filing) | Jul 31 | 1 day | Kanesa-thasan NiranjanChief Medical Officer | SSale | −3.32K | $8.86 | −$29.4K | −1.4%235.9K after | 10b5-1 |
| Feb 15, 2023 (view filing) | Feb 13 | 2 days | Kanesa-thasan NiranjanChief Medical Officer | SSale | −1.79K | $10.69 | −$19.2K | −0.7%239.2K after | |
| Aug 2, 2022 (view filing) | Jul 29-Aug 2 | 4 days | Kanesa-thasan NiranjanChief Medical Officer | SSale | −3.25K | $6.75 | −$21.9K | −1.3%239.3K after | 3 lots |
| Aug 2, 2021 (view filing) | Aug 2 | Same day | Kanesa-thasan NiranjanChief Medical Officer | PPurchase | +6.67K | $15.00 | +$100.0K | New position6.67K after |